1. Switzerland Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Sonova Holding AG

Sonova Holding AG

304.70
EUR
+2.90
(+0.96%)
11.41BMarket Cap
Nov 12Next Earn
Sonova Holding AG
FRA:PHBN
(Frankfurt Stock Exchange)

Recent

price

304.70

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
CHF
121.56
121.02
133.76
28.88
30.14
31.21
36.43
40.24
42.19
45.62
41.32
54.02
62.07
60.82
60.62
60.53
- -
Revenue per Share
17.37
18.44
8.18
5.04
5.33
5.08
5.31
6.08
6.93
7.56
9.23
10.42
10.75
10.08
9.07
7.23
- -
Basic EPS, GAAP
17.52
16.75
22.71
4.68
5.49
5.2
6.45
7.96
8.14
11.18
10.72
13.4
10.45
10.48
11.05
10.61
- -
Free Cash Flow per Basic Share
5.97
5.97
5.95
1.59
1.89
2.05
2.09
2.29
2.59
2.92
- -
3.24
4.44
4.6
4.3
4.4
- -
Dividend per Share
20.02
22.08
23.87
25.81
27.5
28.58
32.02
37.28
36.33
32
43.59
39.46
37.12
41.44
44.7
44
44
Book Value per Share
4.19
5.35
6.11
8.63
9.32
8.09
-3.26
-0.22
-1.69
-6.51
5.17
-8.81
-14.19
-9.53
-5.37
-0.12
-0.12
Tangible Book Value per Share
13
13
13
68
68
66
66
66
66
64
63
62
60
60
60
60
60
Basic Weighted Avg Shares
1,617
1,620
1,795
1,951
2,035
2,072
2,396
2,646
2,763
2,917
2,602
3,364
3,738
3,627
3,613
3,606
- -
Sales/Revenue/Turnover
18.95
18.22
8.66
20.71
21.08
19.05
17.69
18.05
19.39
17.48
19.03
22.6
19.98
18.47
19.92
18.74
- -
Operating Margin (%)
103
78
82
83
85
89
147
135
128
200
223
211
240
246
233
260
- -
Depreciation Expense
231
247
110
341
360
337
349
400
454
483
581
649
648
601
541
431
- -
Net Income, GAAP
11.16
12.55
25.32
11.96
12.37
12.9
14.65
14.93
13.1
2.57
2.53
8.86
8.02
5.84
17.45
14.91
- -
Effective Tax Rate (%)
14.29
15.23
6.11
17.47
17.69
16.27
14.58
15.12
16.43
16.57
22.33
19.29
17.32
16.57
14.96
11.94
- -
Profit Margin (%)
278
341
615
507
569
499
532
582
282
118
1,368
154
409
515
411
895
895
Working Capital
228
242
229
- -
- -
- -
759
609
360
767
1,410
1,080
1,736
1,715
1,328
1,525
1,525
LT Debt
1,345
1,481
1,641
1,774
1,872
1,906
2,131
2,475
2,376
2,029
2,773
2,433
2,231
2,491
2,685
2,636
2,636
Total Equity
13.94
14.47
6.26
18.75
19.59
17.92
14.58
12.99
14.49
15.83
15.3
15.81
16.65
14.57
13.11
12.73
- -
Return on Invested Capital (%)
13.82
15.06
6.26
18.31
19.01
17.44
14.33
12.88
14.47
15.92
15.44
15.35
16.53
14.86
12.74
10.15
- -
Return on Capital (%)
17.79
17.51
7.1
20.3
20.06
18.09
17.5
17.55
18.9
22.14
24.42
25.16
28.01
25.67
21.05
16.32
- -
Return on Common Equity (%)

Capital Structure

CHF

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
ST Debt
432
65
186
LT Borrowings
1,148
- -
1,353
LT Finance Leases
180
162
173
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
60
60
59
Market Capitalization
- -
13,106
10,535

Working Capital

CHF

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
Total Current Assets
1,911
1,655
2,084
Cash, Cash Equivalents & STI
687
511
722
Accounts Receivable, Net
577
529
527
Inventories
469
441
381
Total Current Liabilities
1,500
1,336
1,189
Payables & Accruals
- -
- -
- -
ST Debt
432
65
186
Deferred Revenue
- -
- -
- -

Growth Rates

CHF

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.3%
-0.59%
-1.81%
Free Cash Flow
7.62%
-0.08%
-4.07%
Net Income, GAAP
3.22%
-5.22%
-20.33%
Sales/Revenue/Turnover
6.21%
7.37%
-0.19%
Total Cash Common Dividend
10,066.44%
20,146.2%
2.38%

Semi-annual Revenue

CHF

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
3,627
2025
- -
- -
3,613
2026
- -
- -
3,606

Semi-annual Earnings Per Share

CHF

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
10.08
2025
- -
- -
9.07
2026
- -
- -
7.23

Semi-annual Dividends Per Share

CHF

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
4.6
2025
- -
- -
4.3
2026
- -
- -
4.4
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Sonova Holding AG, a leading provider of innovative hearing care solutions, engages in the design, manufacture, distribution, and sale of hearing instruments and related services. Main products and services include hearing aids across disposable, reusable, and premium lines; cochlear implant systems; bone-anchored and wireless accessories; hearing protection and patient care devices; professional diagnostic and fitting software; and aftercare services such as fitting, repairs, and remote care solutions. The company operates through core brands and product families in hearing health, with professional channels serving audiology clinics, hearing care professionals, and end customers. Latest major company changes include strategic partnerships and alliances in audiology technology, expansion of direct-to-consumer and professional channels, acquisitions and investments in innovative hearing solutions and related accessories, and launches of new product generations and software platforms. The company reports recent reorganizations and operational enhancements to support global distribution, R&D, and digital health initiatives, along with geographic expansion activities. Industry and business segments focus on hearing care and optically linked health technologies with geographic operations spanning Europe, North America, Asia-Pacific, and other regions. Founding year is 1946 with headquarters in Staefa-Zh, Switzerland. Sonova maintains subsidiaries and brand-level operations worldwide, including affiliated entities within its global corporate structure. The company emphasizes advanced audiology products, patient-centered care, and scalable hearing care solutions for diverse customer groups, including individual consumers, clinics, and healthcare providers.

Company News

Company News APIChatGPT

  • reuters.com

    Sonova unveils new AI-powered hearing-aid platform to support growth targets

  • seekingalpha.com

    Sonova Holding AG (SONVY) Q4 2026 Earnings Call Transcript

  • seekingalpha.com

    Sonova Holding AG (SONVY) Discusses Refreshed Strategy and Vision for Next Phase of Growth Transcript

  • reuters.com

    Sonova expects FY revenue at lower end of target range, CEO says in interview

  • seekingalpha.com

    Sonova Holding AG (SONVY) Q2 2026 Earnings Call Transcript

  • seekingalpha.com

    Sonova Holding AG (SONVF) Q4 2025 Earnings Call Transcript

  • wsj.com

    Sonova Shares Jump on Sales Beat, CEO Change

  • seekingalpha.com

    Sonova Holding AG (SONVF) Q2 2025 Earnings Call Transcript